Damao Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.25 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 131.00%
- Profit Growth 115.01%
- Ebitda 83.06%
- Net Worth 8.49%
- Total Assets 24.28%
About Damao Pharmaceutical
Damao Pharmaceutical Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2019 (Five years and nine months 21 days old ). Its registered office is in Daman, Daman And Diu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Girishbhai Patel, Smitesh Patel, and Urjali Patel serve as directors at the Company.
Company Details
-
Location
Daman, Daman And Diu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DD2019PTC009846
-
Company No.
009846
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Apr 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Damao Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urjali Patel
|
Director | 13-Sep-2019 | Current |
|
Girishbhai Patel
|
Director | 20-Apr-2019 | Current |
|
Smitesh Patel
|
Director | 20-Apr-2019 | Current |
Financial Performance of Damao Pharmaceutical.
Damao Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 131% increase. The company also saw a substantial improvement in profitability, with a 115.01% increase in profit. The company's net worth moved up by a moderate rise of 8.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Damao Pharmaceutical?
Unlock access to Damao Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Damao Pharmaceutical?
Unlock and access historical data on people associated with Damao Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Damao Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Damao Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.